William Aird: Rethinking Hemolysis Classification
William Aird, Professor of Medicine at Harvard Medical School, posted on X:
“1/6
RETHINKING HEMOLYSIS CLASSIFICATION
I recently saw an incredibly rare but fascinating case of T-cell large granular lymphocytic (T-LGL)–mediated, DAT-negative hemolysis.
It prompted me to rethink how we classify hemolytic anemia and revise the schematic accordingly.

2/6
We usually divide hemolysis into immune and non-immune:
- Immune → antibody-mediated (autoimmune or alloimmune), DAT-positive
- Non-immune → mechanical, microangiopathic, infectious, toxic
That framework covers >99% of cases.
3/6
But what about the ultra-rare, cell-mediated form, when cytotoxic T or NK cells directly attack red cells or precursors?
- No antibodies.
- No complement.
- DAT-negative.
Mechanism: perforin/granzyme or Fas–FasL–mediated cytotoxicity.
4/6
These are not theoretical.
Occasional cases of LGL leukemia have shown evidence of direct, antibody-independent RBC destruction, essentially a cell-mediated immune hemolysis.
Vanishingly rare, but biologically fascinating.
5/6
So, I’ve updated the diagram.
Under “Immune hemolysis,” I’ve added a side branch:
“Cell-mediated (T/NK-cell cytotoxicity, DAT-negative)”
It’s a footnote in clinical reality but makes the schema more complete for those who enjoy a good hematologic deep dive.

6/6
If you teach or think about hemolysis, this nuance helps connect the adaptive (antibody-mediated) and cellular (cytotoxic) arms of immunity.
Sometimes the exceptions are what remind us how beautifully complex blood can be.”
Stay updated with Hemostasis Today.
-
May 23, 2026, 01:51Paula Greter: Access and Innovation in Hemophilia through ERAH2026
-
May 22, 2026, 17:30Veronica Sanchez: Do You Live with Pain after a Stroke?
-
May 22, 2026, 17:25Maxime Dely: A Simple but Powerful Indicator of Platelet Quality
-
May 22, 2026, 17:24Jim Hoffman: A New Approach to Balancing Host Defense and Tissue Protection
-
May 22, 2026, 17:22Lucia Rugeri: Advancing Multidisciplinary Care for Heavy Menstrual Bleeding in Women with Bleeding Disorders
-
May 22, 2026, 17:20Nour Al-Mozain: Optimizing PBSC Collection Through Real-Time CD34+ Monitoring
-
May 22, 2026, 16:30Buse Bor: New Publication on Therapeutic Interventions for Women with Obstetric APS
-
May 22, 2026, 16:29Danny Hsu: The Reversal Dilemma – Rethinking our approach to DOAC-associated ICH
-
May 22, 2026, 16:28Bartosz Hudzik: High Bleeding Risk Does Not Always Mean Bleeding-Risk Predominance